Tilray Brands, Inc. (TLRY)
7.89
+0.31
(+4.09%)
USD |
NASDAQ |
Feb 19, 16:00
7.92
+0.03
(+0.38%)
After-Hours: 05:41
Tilray Brands Research and Development Expense (Quarterly) : 0.078M for Nov. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 5.456M |
| Aurinia Pharmaceuticals, Inc. | 8.435M |
| Edesa Biotech, Inc. | 1.125M |
| Lexaria Bioscience Corp. | 0.6713M |
| Xenon Pharmaceuticals, Inc. | 76.41M |